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Ectopic or tertiary lymphoid tissues (TLTs) are often
induced at sites of chronic inflammation. They typically
contain various hematopoietic cell types, high endothe-
lial venules, and follicular dendritic cells; and are orga-
nized in lymph node–like structures. Although fibro-
blastic stromal cells may play a role in TLT induction
and persistence, they have remained poorly defined.
Herein, we report that TLTs arising during inflamma-
tion in mice and humans in a variety of tissues (eg,
pancreas, kidney, liver, and salivary gland) contain stro-
mal cell networks consisting of podoplanin T-zone
fibroblastic reticular cells (TRCs), distinct from follicu-
lar dendritic cells. Similar to lymph nodes, TRCs were
present throughout T-cell–rich areas and had dendritic
cells associated with them. They expressed lympho-
toxin (LT)  receptor (LTR), produced CCL21, and
formed a functional conduit system. In rat insulin pro-
moter–CXCL13–transgenic pancreas, the maintenance
of TRC networks and conduits was partially dependent
on LTR and on lymphoid tissue inducer cells express-
ing LTR ligands. In conclusion, TRCs and conduits are
hallmarks of secondary lymphoid organs and of well-
developed TLTs, in both mice and humans, and are
likely to act as important scaffold and organizer cells of
the T-cell–rich zone. (Am J Pathol 2011, 178:1662–1675;
DOI: 10.1016/j.ajpath.2010.12.039)
1662Acute inflammation has evolved to facilitate effective elimi-
nation of pathogens and tumors. It is normally transient and
turned off when the causative stimulus has been eliminated.
Occasionally, the inflammation is sustained and becomes
persistent.1 This complex pathophysiological process is
characterized by the infiltration of target organs, with lym-
phocytes organizing themselves into distinct T- and B-cell–
rich zones. Because these infiltrates show considerable
morphological, cellular, and molecular similarities to sec-
ondary lymphoid organs (SLOs), especially lymph nodes
(LNs), they are referred to as tertiary lymphoid tissues
(TLTs). There is increasing evidence that these TLTs, ob-
served within a wide range of inflamed tissues, are immu-
nologically active and have the potential to cause severe
tissue damage.2–4
Specialized stromal cell types present within inflamed
tissues are thought to be critical for the switch from acute to
chronic inflammation and for disease persistence.1 In par-
ticular, high endothelial venules (HEVs), follicular dendritic
cells (FDCs), and fibroblasts are hallmarks of many TLT
types.2,3 However, the presence and role of T-zone fibro-
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persistence of TLTs has not yet been carefully examined. In
murine SLOs, FDCs and TRCs form a dense three-dimen-
sional (3D) network throughout the B and T zones, respec-
tively.5–7 The TRCs serve as a scaffold for lymphocyte mi-
gration within the T zone.8 They produce the CCR7 ligands,
CCL19 andCCL21, required for T-cell attraction andmotility
and dendritic cell attraction.9–11 They also regulate the sur-
vival of naïve T cells by producing IL-7.10 Finally, they pro-
duce the extracellular matrix (ECM) scaffold that forms a
network of microvessels, called conduits.7,12,13 In LNs,
these conduits drain fluid and small molecules from the
subcapsular sinus to HEVs.13,14 Thus far, no single marker
unambiguously identifies TRCs in murine SLOs. The TRCs
can be identified by their T-zone localization, reticular mor-
phological features, and surface expression of podoplanin
(also referred to as gp38); and the absence of endothelial
(CD31 or LYVE-1), FDC (CD21/35), and hematopoietic
(CD45) markers.6,10,12 In humans, podoplanin has been
widely used as a marker for lymphatic endothelial cells15;
recently, it was used for the identification of FDC16,17 and
cancer-associated fibroblasts.18,19
Reticular networks of podoplanin and BP-3 stromal
cells have also been observed in murine TLTs, such as
pancreatic infiltrates of rat insulin promoter (RIP)–CCL19,
RIP-CCL21, and RIP-CXCL13 animals,20,21 and recently
at sites of acute inflammation and tumors.22 By using the
antibody ER-TR7, similar networks have been visualized
in other murine inflammation models.20,23–25 However,
recent evidence10,12,13 suggests that ER-TR7 stains a
conduit component, rather than TRCs. In human tissues,
such as LNs and arthritic joints, the presence of reticular
cells in the T zone expressing  smooth muscle actin
(SMA), CCL19, and CCL21 has recently been re-
ported.26 However, a detailed characterization of stromal
cells of the T zone has been lacking for murine TLTs and
human SLOs and TLTs.
The formation of TLTs in adult mice is thought to be
governed by the same factors that regulate LN and Pey-
er’s patch (PP) development during embryonic and post-
natal life.2,3 Members of the tumor necrosis factor–lym-
photoxin (LT) family and lymphoid tissue chemokines (ie,
CXCL13, CCL19, and CCL21) are central to this process.
Lymphoid tissue inducer (LTi) cells express cell surface
LT and trigger the LT receptor (LTR) present on
fibroblastic stromal cells, thereby starting extensive he-
matopoietic-stromal cell cross talk.27,28 This induces the
expression of CCL19, CCL21, and CXCL13 and adhesion
molecules by these stromal cells. The chemokines then
attract more LTi cells expressing the chemokine recep-
tors CCR7 and CXCR5 that bind the ligands CCL19/
CCL21 and CXCL13, respectively. Finally, the develop-
ment of HEVs brings in many more lymphocytes, leading
to large T- and B-cell compartments. Consistent with this
model, the expression of LT, LT, tumor necrosis fac-
tor-, CXCL13, CCL19, or CCL21 under the RIP induces
the formation of extensive TLT structures next to pancre-
atic islets.2,3,20,21,29–32 The observation that TLT struc-
tures require LT signaling for their induction and main-
tenance suggested that they also depend on cross talk
between LT hematopoietic cells and LTR stromalcells.33 The LT LTi cells have been shown to be
present in adult spleen.34–36 The observation of LTi-like
cells in pancreatic islets of neonatal RIP-CXCL13 mice37
suggested that they may play a role in TLT development.
The role of LTi cells in this process is controversial,25,38
as is the identity of the LTR-expressing stromal cells.4,28
Herein, we performed a detailed characterization of
stromal cell subsets in murine and human TLTs and in
human SLOs. We provide several lines of evidence sug-
gesting that TRC-like cells exist in human SLOs and in
infiltrates of two chronic immune-mediated inflammatory
diseases in humans [ie, primary biliary cirrhosis (PBC)39
and Sjögren’s syndrome].40 Similar TRC networks were
associated with the T-cell–rich infiltrate of several murine
models of chronic inflammation.21,30 Their phenotype
closely resembled their counterpart in SLOs. We further
dissected the cells and signals required for RIP-CXCL13–
driven formation of ectopic TRCs and provide evidence
that their maintenance is dependent on LT-expressing
LTi cells.
Materials and Methods
Mice
The following mouse strains were used (aged 3 to 6
months): C57BL/6 (B6; Janvier, Le Chenest-Saint-Isle,
France) RIP-LT29 (provided by Mathias Heikenwälder,
University Hospital Zurich, Zurich, Switzerland; originally
from Nancy Ruddle, Yale University, New Haven, CT), non-
obese diabetic (NOD) (Jackson, Bar Harbor, ME), RIP-
CXCL13,21 retinoid-related orphan receptor (ROR)/,41
(provided by Dan Littman, New York University, New
York), and T cell receptor (TCR) / (Jackson). Some
adult (aged 4 months) RIP-CXCL13–transgenic animals
were injected i.p. twice per week for 22 days with 100 g
of soluble murine LTR or control human LFA3 (CD58)
fused to the Fc portion of human IgG1, as previously
described42 (provided by Jeff Browning, Biogen Idec,
Boston, MA). All mice were maintained under pathogen-
free conditions. All mouse experiments were authorized
by the Swiss Federal Veterinary Office.
Human Tissue Samples
Tonsils (n  5) were removed from patients undergoing
routine tonsillectomy, and mesenteric LNs (n  1) and
livers were removed from patients during liver transplan-
tation (normal liver, n 1; PBC liver, n 4; two contained
well-defined TLT structures at several levels). Sjögren’s
syndrome salivary gland tissue (n  10; two contained
well-defined TLT structures at several levels) was ob-
tained for biopsy. All human tissue samples were frozen
in liquid nitrogen. Ethical approval for the use of tissue
samples taken during this study was obtained from the
Birmingham and local Research Ethics Committee (REC
2002/088, LREC 5735, and 06/Q2706/66).
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Target Species Clone or designation Conjugate
Supplier and catalog
number
Primary antibodies for immunofluorescence
staining of human tissue sections
Podoplanin Mouse IgG1 4D5aE5E6 (MCA 2370) Purified AbD Serotec
Podoplanin Mouse IgG1 D2-40 (730-01) Purified Signet
CD3 Mouse
IgG2b
UCHT-1 Purified Peter Beverley (UCL)
CD21 Mouse
IgG2a
HB5 Purified Thomas Tedder (Duke
University)
CCL21 Rabbit IgG1 Purified Abcam ab9851
Podoplanin Rabbit Purified Abcam ab10274
CD11c Mouse IgG1 BU15 Purified Hybridoma
Collagen-1 Goat Purified Southern Biotechnologies
(SB) 01310-01
Laminin Rabbit Purified Sigma L9393
CD31 Mouse
IgG2a
HEC7 (MA3100) Purified Thermo Scientific
Lyve-1 Mouse IgG1 8C Purified David Jackson (Oxford)
Secondary antibodies for immunofluorescence
staining of human tissue sections
Anti-mouse IgG1 Goat FITC SB 1070-02
Anti-fluorescein Goat Alexa488 Invitrogen A11096
Anti-mouse IgG2b Goat Cy5 SB 1090-15
Anti-mouse IgG2a Goat Alexa350 Invitrogen A21130
Anti-rabbit IgG Donkey TRITC Jackson ImmunoResearch
711-026-152
Anti-mouse IgG Donkey Cy5 Jackson ImmunoResearch
715-176-151
Anti-goat IgG Donkey FITC Jackson ImmunoResearch
705-096-147
Primary antibodies for immunofluorescence
staining of murine tissue sections
B220 Rat RA3-6B2 Purified Hybridoma
BP-3 (CD157) Mouse BP-3 Biotin Max D. Cooper
(Birmingham, Alabama)
CCL21 Goat AF457 Purified R&D Systems
CD35 (CR1) Rat 8C12 Purified Hybridoma
CD3 Armenian
hamster
145-2C11 Purified Hybridoma
CD4 Rat H129.19.6 Purified Biolegend
Desmin Rabbit No. 10570 Purified PROGEN
ER-TR7 Rat ER-TR7 Purified Willem van Ewijk (Leiden,
the Netherlands)
Podoplanin (gp38) Syrian
hamster
8.1.1 Purified Developmental Studies
Hybridoma Bank
PECAM-1 (CD31) Rat GC-51 Purified Beat Imhof (Geneva,
Switzerland)
CD11c Armenian
hamster
N418 Biotin eBioscience
VCAM-1 (CD106) Rat M/K2.7 Biotin Hybridoma, ATCC
LTR Rat 4H8 WH2 Purified Axxora Corporation
MAdCAM-1 Rat Meca-89 Biotin Hybridoma, ATCC
PDGFR (CD140a) Rat APA5 Purified eBioscience
PDGFR (CD140b) Rat APB5 Purified eBioscience
CCL21 Goat AF457 Purified R&D Systems
Laminin Rabbit L9393 Purified Sigma
Collagen-1 Goat 1310-01 Purified Southern Biotech
Fibronectin Rabbit F3648 Purified Sigma
Lyve-1 Rabbit 103-PA50 Purified Reliatech
MHC II (I-A/I-E) Rat 2G9 Purified BD Biosciences
PNAd Rat MECA-79 Purified BD Biosciences
Insulin Guinea pig 4012-01 Purified Linco Research
Secondary reagents for immunofluorescence
staining of murine tissue sections
Anti-Syrian hamster IgG Goat Polyclonal Cy3 Jackson ImmunoResearch
Anti-Syrian hamster IgG Goat Polyclonal Biotin Jackson ImmunoResearch
Anti-Syrian hamster IgG Goat Polyclonal Cy3 Jackson ImmunoResearch(table continues)
, vascu
eral lym
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Tissue Samples
Acetone-fixed 5-m sections of snap-frozen tissues were
prepared and stained, as previously described,43 with
the antibodies listed in Table 1. Slides were mounted in
2.4% w/v 1,4-diazabicyclo(2,2,2)octane (Aldrich, Gilling-
ham, England) in 10% v/v glycerol (Fisons Scientific,
Loughborough, UK) in PBS (pH, 8.6) and analyzed by
confocal microscopy (LSM 510; Carl Zeiss Ltd, Welwyn
Garden City, England).
Immunofluorescence Microscopy on Murine
Tissues
To visualize functional conduits, Texas Red–labeled 10-kDa
dextran (Invitrogen AG, Basel, Switzerland) was injected i.v.
andmice were sacrificed 5minutes later. The pancreas was
removed, fixed in four percent paraformaldehyde at 4°C,
and saturated in 30% sucrose for 3 hours at 4°C before
embedding in Optimal Cutting Compound (OCT, Tissue-
Tek; Sakura), followed by freezing in an ethanol dry ice
bath. For all other experiments, dissected tissues were em-
bedded in OCT without prior fixation. Immunofluorescence
stainings were performed on cryostat sections (8 m) with
the antibodies listed in Table 1, as previously de-
scribed.10 For podoplanin and CCL21, primary antibod-
ies were revealed using biotinylated secondary antibod-
ies and streptavidin–horseradish peroxidase, followed by
tyramide signal amplification (kit 22; Invitrogen), accord-
Table 1. Continued
Target Species
Anti-Armenian hamster IgG Goat
Anti-guinea pig Goat
Anti-rat IgG Donkey
Anti-rat IgG Donkey
Anti-goat IgG Donkey
Anti-rabbit IgG Donkey
Anti-rabbit IgG Donkey
Streptavidin
Streptavidin
Streptavidin
Primary reagents for flow cytometric analysis
of murine cells
IL-7R (CD127) Rat
CD4 Rat
CD3 Armenian
hamster
CD11c Armenian
hamster
CD19 Rat
CD45 Rat
Secondary reagents for flow cytometric
analysis of murine cells
Streptavidin
Streptavidin
Anti-human IgG Goat
Anti-rat IgG (HL) Donkey
APC, allophycocyanin; FITC, fluorescein isothiocyanate; MHC, major
adhesion molecule; TRITC, tetramethylrhodamine isothiocyanate; VCAM
molecule; PDGFR, platelet derived growth factor receptor; PNAd, periphing to the manufacturer’s instructions; however, a boratebuffer (0.1 mol/L in PBS, pH 8.5) was used for tyramide
dilution. Images were acquired on a microscope (Ax-
ioplan) with AxioCam MRm (Zeiss) or on a different mi-
croscope (DM IRE2) with laser-scanning confocal head
TCS SP2 AOBS (acoustic optical beam splitter; Leica,
Nunningen, Switzerland).
Vibratome Sections and Immunofluorescence
Staining
Isolated peripheral LNs and pancreas were fixed overnight
at 4°C in freshly prepared one percent paraformaldehyde
(in PBS), washed, and embedded in four percent low-gell-
ing agarose (Sigma) in PBS; 100- to 200-m sections were
cut using a vibratome (Microm HM 650V). Sections were
blocked with one percent bovine serum albumin for 1 hour
and stained for at least 3 hours or overnight with the anti-
bodies listed in Table 1. Subsequently, sections were
washed extensively in PBS and embedded using Mowiol
4-88 (Merck, Darmstadt, Germany). Images were taken with
an upright microscope (Axio Imager with ApoTome; Zeiss).
The 3D image reconstructions were made with Axio Vision
software version 4.8.1 (Zeiss).
Isolation of LTi Cells
Peripheral LNs, spleen, or pancreas was dissected from
euthanized mice. The capsule of the LNs was opened with
26-gauge syringe needles; the spleen and pancreas were
cut into small pieces. The LN, spleen, and pancreas pieces
one or designation Conjugate
Supplier and catalog
number
clonal Biotin Jackson ImmunoResearch
clonal Biotin Vector
clonal APC Jackson ImmunoResearch
clonal Alexa488 Molecular Probes
clonal Biotin Jackson ImmunoResearch
clonal Alexa488 Molecular Probes
clonal Cy3 Jackson ImmunoResearch
APC Biolegend
Alexa488 Molecular Probes
Cy3 Jackson ImmunoResearch
34 PE eBioscience
.5 APC BioLegend
-2C11 FITC BioLegend
8 FITC eBioscience
FITC BioLegend
11 PE-Cy7 BioLegend
317-87 PE eBioscience
317-82 PE-Cy5 eBioscience
-066-098 Biotin Jackson ImmunoResearch
-116-153 PE Jackson ImmunoResearch
mpatibility complex; PE, phycoerythrin; PECAM, platelet endothelial cell
lar cell adhesion molecule; MAdCAM, mucosal addressin cell adhesion
ph node addressin.Cl
Poly
Poly
Poly
Poly
Poly
Poly
Poly
A7R
GK1
145
N41
6D5
30-F
12-4
35-4
109
712
histocowere then digested with gentle stirring for 20 minutes at
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collagenase IV (Worthington, Lakewood, NJ), 40 g/mL
DNase I (Roche, Basel, Switzerland), and two percent (v/v)
FBS. Collagenase D, 1 mg/mL (Roche), was added; and
digestion continued for another 20 minutes. Every 10 min-
utes, the suspension was gently pipetted to break up re-
maining aggregates until no visible fragments remained.
During the last pipetting, EDTA was added to a final con-
centration of 5 mmol/L to further reduce cell aggregates.
Cells were then passed through a 40-m mesh, washed
twice, and resuspended in RPMI 1640 medium containing
two percent (v/v) FBS and 5 g/mL DNase I at a maximum
concentration of 2 107 cells/mL. The cell suspension was
then underlayed with 2.5 mL of mixed Lympholyte M (Ce-
darlane, Burlington, VT) at 25°C and centrifuged at 750 g
for 20 minutes. The cells at the gradient interphase were
collected and used for flow cytometry.
Flow Cytometry
Stainings were performed with 1 105 to 1.5 106 cells in
96-well V-bottom plates (Falcon; Milian AG, Geneva, Swit-
zerland). Cells were blocked with one percent normal
mouse serum and stained with the antibodies listed in Table
1 in 25 L of PBS containing two percent FBS, 2 mmol/L
EDTA, and 0.1% NaN3; the cells were washed twice with
200 L of this buffer after each step. Unconjugated primary
antibodies were detected with the secondary reagents
listed in Table 1. Data were acquired on a flow cytometer
(FACSCanto; BD Biosciences, Basel, Switzerland) and an-
alyzed with Flowjo software version 9.1 (TreeStar, Ashland,
OR). To detect surface expression of LTR, cells were
pretreated with FcR blocking antibody (2.4.G2; BD Bio-
sciences) and 0.5% normal mouse and rat serum. The
LTR-Fc (provided by J. Browning) and the FN14-Fc
(provided by P. Schneider) (both human IgG1) were
added and detected using a biotinylated goat anti-hu-
man IgG (Jackson ImmunoResearch, Newmarket, UK)
pretreated for 30 minutes with four percent normal mouse
and rat serum. Finally, streptavidin-phycoerythrin (eBio-
science, San Diego, CA) was added, along with other
surface markers.
In Situ Hybridization
Mice were anesthetized and perfused with PBS, followed by
four percent paraformaldehyde in PBS. The pancreas was
then removed and further fixed in four percent paraformal-
dehyde overnight and saturated in 30% sucrose for 3 hours
at 4°C before embedding in OCT, followed by freezing in an
ethanol–dry ice bath. Frozen sections (8 m) were then
treated as previously described9 and hybridized overnight
at 60°C with a CCL21-antisense digoxigenin-labeled ribo-
probe in hybridization solution. After washing at high strin-
gency, sections were incubated with sheep anti-digoxige-
nin (Roche), followed by alkaline phosphatase–coupled
donkey anti-sheep antibody (Jackson ImmunoResearch
Laboratories) and developed with Nitroblue-tetrazolium-
chloride (NBT, Bio-Rad) and 5-Bromo-4-chloro-3-indolyl
phospate (BCIP, Sigma).Statistical Analysis
Statistical significance was determined using an unpaired
two-tailed Student’s t-test. A Levene’s test for homogeneity
of variances was used to check for equal variance. An
unpaired two-tailed Student’s t-test for unequal variance
was used. P  0.05 indicated significance.
Results
Podoplanin Identifies T-Zone Reticular Networks
in Human Secondary Tissues and TLTs
To determine whether human SLOs and TLTs develop a
TRC network similar to murine SLOs,10,12 we analyzed his-
tological sections for the presence of podoplanin reticular
cells. Three different antibodies to podoplanin comparably
labeled the reticular networks of the T zone in both human
LNs and tonsils (Figure 1, see Supplemental Figure S1 at
http://ajp.amjpathol.org), while labeling most strongly FDCs
and lymphatic vessels. The podoplanin cells of the T zone
could be distinguished from FDCs through their localization
among T cells and the absence of CD21 (Figure 1) and from
lymphatic vessels by their reticular morphological features
and absence of the endothelial marker CD31 and the lym-
phatic marker Lyve-1 (see Supplemental Figure S2 at http://
ajp.amjpathol.org). Ectopic lymphoid infiltrates occurring in
chronically inflamed nonlymphoid tissues, such as PBC
liver or Sjögren’s syndrome salivary gland, showed sim-
ilar reticular networks of podoplanin CD31Lyve1
cells in some, but not all, CD3 T-cell areas (Figure 1, see
Supplemental Figures S2 and S3 at http://ajp.amjpathol.
org). Similar to LNs and tonsils, podoplanin- and CD21-
coexpressing FDCs were observed as dense clusters
inside B-cell rich zones. However, in noninflamed liver,
podoplanin-expressing cells were virtually absent. These
results suggest that TRC-like cells are present in human
SLOs and can develop at sites of chronic inflammation.
Podoplanin Stromal Cells in Human Tissues
Share Many Properties with Murine TRCs
To test whether these TRC-like cells observed in human
tissues share other properties with TRCs characterized in
murine LNs and spleen, we further defined these cells his-
tologically. In T zones of LNs and tonsils, podoplanin cells
formed a dense reticular network that associated with ECM
molecules (ie, collagen-1, laminin, and fibronectin) (Figure
2, data not shown) in structures that resemble, in their com-
position and morphological features, the conduits found in
murine SLOs.13 Podoplanin cells colocalized with CCL21
protein and were in close contact with CD11c-positive den-
dritic cells (Figure 2). Similarly, at sites of chronic inflamma-
tion, such as PBC liver and Sjögren’s syndrome salivary
gland, but not in healthy liver, ECM fibers were observed in
association with podoplanin cells in T cell–rich infiltrates
(Figure 2). To a variable extent, TRC-like cells displayed
some detectable CCL21 protein and were associated with
DCs. Together, these data indicate a high similarity of the
in cel
Scale ba
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and human lymphoid tissues.
Podoplanin Stromal Cells Are Present in
Murine TLTs
To study the development and properties of TLT-associated
TRCs in greater detail, we tested several mouse models
displaying lymphocytic tissue infiltration for the presence of
these stromal cells: NOD mice that are a model of autoim-
mune diabetes mellitus and developmostly smaller pancre-
atic lymphoid infiltrates44 and RIP-LT transgenic and RIP-
CXCL13mice that form large infiltrates of mostly naïve T and
B cells in kidney and pancreas, respectively, without caus-
ing overt disease.21,29,30 Similar to murine LNs, reticular
podoplanin cell networks were present in the T- but not the
B-cell–rich areas in TLTs of all three mouse models. These
fibroblastic cells showed a surface phenotype distinct from
podoplanin CD31high blood vessels and podoplanin/
lyve1 lymphatic vessels associated with the infiltrate, in
addition to their difference in cell morphological features
Figure 1. Podoplanin CD21 reticular cell networks are associated with C
SLOs, such as LNs and tonsils, and TLTs, such as inflamed PBC liver (n  2
Healthy liver that expressed little podoplanin served as a control. Podoplan
magnification of the T-cell–rich zone is shown in the two right columns.and organization (Figure 3, A and B; see SupplementalFigure S4 at http://ajp.amjpathol.org). Although large and
intermediate infiltrates with well-developed T-cell areas
were always associated with a reticular podoplanin cell
network, smaller infiltrates without a T zone were often lack-
ing it (not shown). A higher magnification showed that the
podoplanin stromal cells also expressed desmin and sur-
rounded conduit-like structures recognized by the ER-TR7
antibody, similar to LNs (Figure 3C). Contrary to a previous
report,21 we occasionally found CD35 FDCs inside the
B-cell follicles of large RIP-CXCL13 infiltrates. However, the
podoplanin cell network in the T zone was always CD35
(Figure 3D), suggesting the presence of two distinct stro-
mal cell networks. Therefore, TLTs in all three tissue infil-
tration models displayed reticular podoplanin cell net-
works with a close resemblance to the TRC network of the
LN T zone.
T-Zone Reticular Networks Share Phenotypic
and Functional Features with LN TRCs
To further compare the phenotype of podoplanin CD31
cell areas in human LNs and TLTs. Immunofluorescence analysis of human
flamed salivary gland from a patient with Sjögren’s syndrome (SS) (n  2).
ls are shown in green; CD21 FDC, red; and CD3 T cells, blue. A higher
rs  100 m.D3 T-
) and in
stromal cells found in TLTs with their counterparts in
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AJP April 2011, Vol. 178, No. 4LNs,10,12 a panel of markers was tested on pancreatic infil-
trates of RIP-CXCL13–transgenic mice, which, among the
three mouse models, displayed the highest frequency of
large infiltrates and lymphoid tissue structures. Confocal
microscopic images showed that many TRC markers, in-
cluding BP-3, vascular cell adhesion molecule-1 (VCAM-1),
platelet-derived growth factor receptor (PDGFR)/, and
LTR, colocalized with podoplanin staining (Figure 4A).
Comparable to LNs,10 most CCL21 protein was localized in
conduit-like structures that were enwrapped by podopla-
nin stromal cells (Figure 4B). By using in situ hybridization
analysis, we detected Ccl21 mRNA expression on HEVs
and in a reticular pattern in the T-cell–rich zone of pancre-
atic infiltrates, indicating that the CCL21 protein is locally
produced (Figure 4C). To determine whether TLTs also form
a conduit system, as found in SLOs,13,14 ectopic pancreatic
infiltrates of RIP-CXCL13 transgenic (tg) mice were labeled
with antibodies to podoplanin and various ECM molecules.
A 3D reconstruction of confocal microscopic images, ob-
tained from thick vibratome sections, confirmed that TLTs
develop 3D networks of podoplanin cells wrapping
around laminin matrix structures, similar to LNs (Figure
4D). These structures consisted of a cellular layer express-
ing podoplanin, a basement membrane containing fi-
bronectin and laminin, and a core containing collagen-1
(Figure 4E). Pancreatic infiltrates in prediabetic NOD mice
displayed matrix structures with the same composition (Fig-
Figure 2. The podoplanin CD21 cell network in human tissues is asso-
ciated with ECM fibers, the chemokine CCL21 and CD11c dendritic cells.
Immunofluorescence analysis of human SLOs, such as LNs and tonsils; and
TLTs, such as inflamed PBC liver and inflamed salivary gland [Sjögren’s
syndrome (SS)]. Healthy liver served as a control. Podoplanin (green), col-
lagen-1 (red), laminin (blue), CCL21 (red), and CD11c (red) in CD3 T-cell
areas are shown. Scale bars  100 m.ure 4E). The functionality of the conduits present in RIP-CXCL13 tg pancreata was demonstrated by the rapid
transport of i.v. injected fluorescent tracer (dextran–Texas
Red) that highlights the ER-TR7 reticular network within
minutes after injection (Figure 4F). Similar to LNs, major
histocompatibility complex class II DCs were associated
on the outside of the podoplanin cells, possibly retrieving
antigen from the conduit lumen13 (Figure 4G). In summary,
functional conduits develop in T-cell–rich areas of TLTs and
are tightly associated with TRCs, the likely producers of
these ECMmolecules. Because of the high phenotypic and
functional resemblance of TRC-like cells in TLTs with their
counterpart in SLOs, we will refer to them as TRCs as well.
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Figure 3. The TLTs developing in murine models of chronic inflammation
form a network of podoplanin stromal cells in the T zone, similar to LNs.
Immunofluorescence analysis of frozen sections of pancreas from NOD and
RIP-CXCL13 tgmice and kidney from RIP-LT tgmice and peripheral LNs.
A: B220 B cells (green) and CD3 T cells (red), the TRC marker podoplanin
(podo, red) combined with the endothelial marker CD31 (green) in serial
sections. Tg pancreata did not show reticular podoplanin staining typical
for TRCs (data not shown). Scale bar  100 m. i indicates islet. B: Infiltrate
labeled with podoplanin (red), the lymphatic vessel marker Lyve-1 (green), and
DAPI nuclei (blue). Arrows indicate lymphatic vessels; and arrowheads, the
more abundant fibroblastic reticular cells. Scale bar  100 m. C: Higher-
magnification images of the T-cell–rich zone of the infiltrate labeled with
podoplanin (red) and desmin and the conduit marker ER-TR7 (green). Scale
bar  20 m. D: The podoplanin (red) and CD35 (green) staining showing
two distinct stromal cell networks in infiltrates of RIP-CXCL13 pancreas.
Scale bar  100 m. Data are representative of at least three independent
experiments.
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Figure 4. Phenotype of podoplanin stromal cells and matrix structures in T-cell–rich zones of pancreatic infiltrates in RIP-CXCL13 tg mice. A: Confocal
immunofluorescence analysis of sections stained with markers for podoplanin (red) and BP-3, VCAM-1, PDGFR, PDGFR, and LTR (all green). Scale bars 
10 m. B: Immunofluorescence analysis of pancreatic sections of RIP-CXCL13 tgmice labeled with antibodies against CCL21 (green) and podoplanin (red). Scale
bar 2 m. Data are representative of three independent experiments. C: In situ hybridization analysis for Ccl21 transcripts in pancreatic infiltrates of RIP-CXCL13
tg mice. Tg pancreas showed only Ccl21 transcripts on lymphatic vessels distant from the islets (not shown). Scale bar  100 m. B indicates B zone; T, T
zone; i, islet. Confocal immunofluorescence images from vibratome (D and G) or 8-m-thick sections (E and F). D: The 3D reconstruction of images from
T-cell–rich zones of pancreatic infiltrates of RIP-CXCL13 tg mice and of LNs labeled with podoplanin (red) and laminin (green). Scale bars 5 m. E: T-cell–rich
zone in sections from RIP-CXCL13 tg and NOD pancreas labeled with antibodies against the TRC marker podoplanin (red) and the conduit markers fibronectin
(green), laminin (red), and collagen-1 (green). Scale bars  2 m. F: Pancreas sections of RIP-CXCL13 tg mice that were injected i.v. with the tracer
dextran–Texas Red 10 minutes before isolating and fixing the tissue. Sections were costained with antibodies against ER-TR7 (green) and podoplanin (blue). Scale
bar  2 m. G: T-cell–rich zone of infiltrates in RIP-CXCL13 tg pancreas labeled with podoplanin (red), laminin (green), and MHC II (blue). Scale bar  5 m.
Data are representative of at least two independent experiments.
1670 Link et al
AJP April 2011, Vol. 178, No. 4Maintenance of Ectopic TRC Networks and
Conduits Is Largely LT Dependent
The formation and maintenance of several lymphoid struc-
tures in CXCL13-transgenic pancreata is known to be LT
and LTR dependent, including HEVs, BP-3, and CCL21
stromal cells.21 To determine whether LTR signaling was
also involved in the maintenance of podoplanin TRC net-
works and conduits in RIP-CXCL13 tg mice, they were
treated for 22 days with LTR-Fc fusion protein, leading to
the disappearance of most large infiltrates (see Supplemen-
tal Figure S5A at http://ajp.amjpathol.org).21 The remaining
infiltrates showed small T-cell–rich zones that correlated
with a marked reduction in the extent of the reticular TRC
network (podoplanin CD31Lyve1) and of CD31 blood
vessels and Lyve1 lymphatic vessels (Figure 5, A and B).
Surprisingly, staining with antibodies against podoplanin,
fibronectin, laminin, and collagen-1 revealed that the overall
structure of the small remaining TRC network and conduits
was not altered in LTR-Fc–treated mice (Figure 5C, see
Supplemental Figure S5B at http://ajp.amjpathol.org). In
some infiltrates, the expression of the chemokine CCL21
was still detectable after LTR-Fc treatment but always in a
much reduced area (Figure 5D), confirming an earlier re-
port21 and correlating with the smaller podoplanin TRC
network. Therefore, the maintenance of functional and well-
developed T zones in RIP-CXCL13 tgmice, including TRC
networks and their associated conduits, is partially depen-
dent on continuing LTR signaling.
LTi Cells Are Present in Adult Secondary
and TLTs
To test if LTi cells could play a role as the LT source in the
formation of TLTs and LTR TRC networks in particular,
we crossed RIP-CXCL13 tg mice to mice deficient in the
transcription factor ROR, which lack LTi cells and, conse-
quently, all LNs and PPs.41 We confirmed by flow cytometry
that few CD4 CD3 CD45 LTi cells expressing IL-7R
and LTR ligands can be found in the LNs and spleen of
adult wild-type mice (Figure 6A), as previously re-
ported.35,36,45 Consistent with the ROR requirement of LTi
cell development, cells with this phenotype were com-
pletely absent from spleens of adult ROR/ mice (Figure
6A), confirming an earlier report35 on ROR/ bone mar-
row chimeras. The CD4 CD3 cells expressing IL-7R
and LTR ligands were also detected in the pancreas of
adult RIP-CXCL13–transgenic mice, but not in nontrans-
genic littermates or transgenic mice on an ROR-deficient
background (Figure 6B, data not shown). In the three
mouse strains, we did not obtain strong evidence for CD4
LTi cells because most CD4 CD3 cells were negative for
IL-7R and LTR ligands.46 Strikingly, in RIP-CXCL13–
transgenic pancreas, the LTi frequency was in a similar
range as in the SLOs of adult mice (Figure 6, A and B).
Histological analysis showed that most IL-7R CD3 cells
localized to perifollicular regions in the pancreatic infiltrates,
similar to adult LNs and spleen (Figure 6C).45 The pheno-
type and localization of these cells in adult tissues suggest
they are LTi cells. This finding raises the possibility of crossβ
β β
β
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Figure 5. Maintenance of the ectopic TRC network and the conduit
system in RIP-CXCL13 tg pancreas is partially LTR dependent. Immu-
nofluorescence analysis of 8-m-thick pancreas sections from adult RIP-
CXCL13 tg mice (aged 4 months) treated twice per week for 22 days with
100 g of soluble LTR-Fc or control LFA-3-Fc fusion proteins. Data are
representative of three mice per group. A: Serial frozen sections were
stained for CD3 T cells (red) and B220 B cells (green) and for podo-
planin (red) and CD31 (green). Scale bar  100 m. B: Staining of an
infiltrated islet for podoplanin (red), lyve-1 (green), and DAPI nuclei
(blue), with the clustered DAPI cells representing mainly infiltrating T
and B cells. Lymphatic vessels appear in yellow (podoplaninlyve1);
and reticular fibroblasts in red (podoplaninlyve1). Right: A higher
magnification of the infiltrate is shown with the vascular marker CD31
instead of DAPI (blue). Most podoplanin cells (arrowheads) show
reticular morphological features and absence of vascular markers
(Lyve1CD31). C: Confocal images showing podoplanin cells (red)
and fibronectin conduits (green) in the T-cell–rich region. Scale bar  10
m. D: Immunofluorescence analysis of CCL21 (green) expression in the
podoplanin region. Scale bar  100 m.
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same zone.
Formation of Large Infiltrates in RIP-CXCL13–
Transgenic Mice Is Dependent On ROR But
Not T Cells
To test whether LTi cells play a role in the formation and
maintenance of TLTs, we performed a histological analysis
of pancreatic infiltrates in ROR-deficient RIP-CXCL13 tg
mice. Hematoxylin-stained sections revealed a striking de-
ficiency in the formation of large infiltrates in these mice
(Figure 6D). Only large infiltrates (more than 300 cells) have
previously displayed clearly defined T- and B-cell–rich
zones, along with extensive BP-3 and CCL21 expression.21
Therefore, we analyzed the composition and organization of
infiltrates in ROR-deficient RIP-CXCL13 mice using immu-
nofluorescence microscopy. The small and few medium-
sized infiltrates in these mice consisted of B cells and a few
α
β
γγ γ
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T-T cells that were not well segregated (Figure 6E). Distinctpodoplanin TRC networks were lacking within the infil-
trates while they were present within the spleen (data not
shown). Podoplanin was only detected on the islet capsule
and lymphatic vessels, similar to wild-type pancreata. The
TRC-associated conduits were mostly absent, based on
stainings for fibronectin, collagen I, laminin, ER-TR7, and
CCL21 (Figure 6E, see Supplemental Figure S6 at http://ajp.
amjpathol.org). Interestingly, PNAd- and MAdCAM1-posi-
tive HEVs were also strongly reduced in the infiltrates (see
Supplemental Figure S6 at http://ajp.amjpathol.org). To ex-
clude that the failure to develop TLTs in ROR/mice was
because of altered expression of LT on B cells, we com-
pared wild-type with ROR/ B cells by flow cytometric
analysis. Yet, no difference in LTR-Fc staining could be
detected(seeSupplementalFigureS7athttp://ajp.amjpathol.
org). In addition to lacking LTi cells, ROR/ mice have
strongly reduced numbers of mature T cells41 and lack type
17 helper T cell and natural killer p46 cell subsets.47 To
exclude a role for T cells in TLT formation, TCR-deficient
γ
Figure 6. The ROR-dependent LTi cells are pres-
ent in adult wild-type spleen and pancreatic infil-
trates of adult RIP-CXCL13 tgmice and are critical
for the development of larger pancreatic infiltrates
with TRC networks and conduit systems. A: Flow
cytometric analysis of single-cell suspensions pre-
pared from adult peripheral LNs and the spleen of
ROR/ and ROR/ mice. Dot blots are pre-
gated for CD45 cells. Gates indicate CD4 CD3
(T cells; red) and CD4 CD3 CD11c CD19 (LTi
like; blue) populations (n  3). Histograms show
IL-7R expression on these two populations and
LTR ligand expression on the CD4 CD3 LTi
cell population, detected with LTR-Fc compared
with the control FN14-Fc fusion protein. B: Hema-
topoietic cells were isolated from the pancreas of
adult RIP-CXCL13 tg mice on an ROR/ or
ROR/ background. Dot blots are pregated for
CD45 cells and show CD4 CD3 CD11c
CD19 (LTi-like; blue) and CD4 CD3 CD11c
CD19 (red) populations (n  3). Histograms
show IL-7R and LTR ligand expression on these
two populations. C: Serial frozen sections of pe-
ripheral LNs, spleen, and pancreas of RIP-CXCL13
tg mice were stained with antibodies to IL-7R
(red) and CD3/CD11c (green). Arrowheads indi-
cate IL-7R CD3 CD11c LTi-like cells in peri-
follicular regions. Scale bar  100 m. A through
C: Data are representative of at least three inde-
pendent experiments. B, B cell-rich zone; T, T cell
rich zone. D: Pancreata from RIP-CXCL13 tgmice
crossed onto the ROR/ and TCR/ back-
ground were sectioned (10 m), and every 15th
section was stained with hematoxylin and ana-
lyzed for the frequency and size of islet-associated
mononuclear infiltrates. Results were derived from
100 to 200 islets in each of the three transgenic
mice per group (littermates aged 7 to 12 weeks).21
The frequencies of small (5 to 30 hematopoietic
cells/infiltrate in a section), medium (31 to 300
cells), and large (greater than 300 cells) infiltrates
and total infiltrates are shown. Arrow indicates
the striking reduction of large infiltrates in tg
mice on a ROR/ background. E: Sections of
RIP-CXCL13 tg pancreata on an ROR/,
ROR/, or TCR/ background were labeled
for CD3 T cells (red) and B220 B cells (green).
Examples of the largest infiltrates in each mouse
are shown. Scale bar 100 m. The white squares
indicate the area chosen in the consecutive sec-
tions to show staining for podoplanin cells (red)
and laminin (red) and collagen-1 (green)
conduits.γRIP-CXCL13 tg mice were analyzed. These mice showed
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cells. Interestingly, extensive podoplanin cell networks
and fibronectin conduits developed in central parts of the
B-cell–dominated infiltrates (Figure 6E, data not shown). In
addition, PNAd andMAdCAMHEVs also developed nor-
mally (see Supplemental Figure S6 at http://ajp.amjpathol.
org). These data indicate that the presence of LTi and/or
possibly natural killer p46, but not T cells, is required for
the development of large LN-like structures in adult RIP-
CXCL13 pancreas, including TRC networks, conduits,
and HEVs.
Discussion
Stromal cells may play a key role in the switch leading
from acute resolving to chronic persistent inflammation.1
Therefore, we performed a comprehensive analysis of
reticular stromal cells arising in various types of TLTs in
human disease and murine models of inflammation in
which TLTs form. We found that the T-cell–rich region of
TLTs contains a TRC-like stromal cell type similar to LNs.
It is distinct from FDCs in B zones. Therefore, larger TLTs
closely replicate the stromal cell organization of SLOs
that is critical for T- and B-zone compartmentalization.
In TLTs of NOD, RIP-LT, and RIP-CXCL13 transgenic
mice, extensive T-zone stromal cell networks were identified
based on the following surface phenotype: podoplanin
CD31 CD35. These cells also expressed other TRC
markers, including LTR and its potential downstream tar-
gets (ie, BP-3 and VCAM-1).10,12 The coexpression of
PDGFR, PDGFR, and desmin is consistent with a mes-
enchymal origin for these cells and suggests that they may
be functional myofibroblasts similar to their counterparts in
LNs and wound healing.10 In support of this notion, we
observed low SMA expression in these cells (data not
shown). The cell morphological features were characterized
by long and fine processes typical for fibroblastic reticular
cells and distinct from endothelial vessels. They wrapped
around ECM structures comparable in composition and
organization to the conduits in SLOs,7,12–14 extending pre-
vious studies20,23–25,48,49 showing reticulin and ER-TR7
staining in TLTs. We demonstrate herein that these con-
duits contain CCL21 and are functional because they can
transport small-molecular-weight molecules. The elucida-
tion of their precise function for TLT function will need
further work. Thus far, functional conduits had only been
described for LNs, spleen, and thymus.14,50,51 Similar to
the two latter organs, it seems plausible that conduits in
TLTs start next to blood vessels and drain the exudate,
including blood-borne molecules and blood serum. In
conclusion, the phenotype, organization, and compart-
mentalization of TRC-like cells, found in larger murine
TLTs, are indistinguishable from their counterparts in
SLOs.
One of the key functions of TRCs in SLOs is the secretion
of CCL19 and CCL21.9,10 During the past few years, ex-
pression levels of CCL19 and CCL21 have been reported
for various murine TLTs2,3,49 and occasionally in tu-
mors.22,52 The CCL21 protein staining in murine TLTs was
associated with HEVs and lymphatic vessels.2,3 ReticularCCL21 protein staining was previously reported in RIP-
CXCL13 tg infiltrates.21 Herein, we show that most reticular
CCL21 protein staining localizes to the conduits, suggest-
ing active chemokine transport. Because CCL21 transcripts
are also found in a reticular pattern throughout the T zone,
it is likely that the podoplanin stromal cells forming a 3D
network are the major local CCL21 source mediating the
attraction of CCR7 T cells and DCs. Indeed, DCs, presum-
ably CCR7, were often observed immediately adjacent to
the podoplanin cells, suggesting active adhesion of DCs
to this network, similar to LNs.8,53 T cells localized within the
TRC network, suggesting that TRC-derived CCL21 pro-
motes T-cell attraction and local motility that is thought to be
critical for efficient selection of the rare antigen-specific T
cells in SLOs.54 Therefore, we propose that TRC-like cells in
TLTs reproduce both the structure and function of T zones
in SLOs. They form a functional scaffold that brings together
T cells with antigen-bearing DCs, thereby driving the local
adaptive immune response, in addition to its potential role in
angiogenesis of blood and lymphatic vessels. This notion is
supported by a recent molecular analysis22 of TRCs from
LNs and sites of inflammation and tumors, where TRCs
were a source of transcripts for IL-7 and CCL19/21 and of
angiogenic factors.
The second reticular stromal cell type present in SLOs,
FDCs, has been previously described in many types of
murine TLTs using CD35 and FDC-M1 as FDC-specific
markers.2,3 In RIP-CXCL13 tg mice, only large infiltrates
contained CD35 FDC networks that localized among B-
cell–rich areas and were not in contact with T cells, DCs,
and HEVs. They were podoplaninlow and PDGFR/ and
did not associate with CCL21 protein and conduits. There-
fore, FDCs and TRCs found in TLTs are two separate retic-
ular cell types with distinct anatomical localization (B- or
T-cell zones) and function. In addition to providing structural
support, we propose that these two networks and their
chemokine expression profiles provide the underlying orga-
nizing principle of B- and T-zone segregation observed in
many pathological TLTs,2,3 similar to their physiological
counterparts in SLOs.55 How they develop and influence
the local regulation of immune responses during disease
remains to be shown.
Although FDCs have been well characterized in human
SLOs and TLTs, little is known about the stromal cells of the
T zone.2,3 Their presence in SLOs was described in several
morphological studies56,57 showing a reticular network in T
zones. Recently, a network of SMA cells colocalizing with
CCL19 and CCL21 expression was conserved in the SLOs
and TLTs of patients with rheumatoid arthritis.26 Herein, we
extend these findings by showing that these cells in SLOs
and TLTs resemble each other, based on their surface
phenotype (podoplanin CD21) and function (ECM pro-
duction and conduits). Podoplanin CD21 TRCs had long
cell processes, formed a 3D reticular network, localized to
T-cell–rich zones, and associated with complex ECM struc-
tures resembling conduits and with CCL21 protein and
CD11c DCs. When cultured in vitro, these podoplanin
cells exhibited typical fibroblast morphological features and
showed high expression of ECM molecules and variable
levels of SMA (our unpublished data), similar to their mu-
rine counterparts12 (our unpublished data). Within the same
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and ECM associated with the TRCs that could indicate
different degrees of TRC differentiation or activation. The
ECM staining, similar to that observed in LN T zones, has
previously been described in the samples of patients with
multiple sclerosis, suggesting that conduits and possibly
TRC-like cells may be present in many more sites of chronic
inflammation.58 In summary, TRC-like cells are a frequent
component of ectopic infiltrates associated with human dis-
ease and closely resemble their SLO counterparts. They are
likely to contribute, together with FDCs, to the overall orga-
nization and possible pathogenic function of human TLTs.
Given the frequent presence of TRCs at sites of chronic
inflammation, understanding their development becomes
an important issue. In this study, we show that the mainte-
nance of the complex TRC network with its conduit struc-
tures within infiltrates of RIP-CXCL13 transgenic mice is
partially dependent on LTR signals, reminiscent of previ-
ous observations with HEVs.21,33 Other unidentified recep-
tors appear to contribute to the formation of small and me-
dium-sized infiltrates containing small TRC networks, with
possible candidates being tumor necrosis factor-R1 and
CD30.12,59 We propose that LTR signals may be critical for
the development and/or maintenance of larger and more
differentiated stromal cell compartments, as observed in
large infiltrates. The LTR signaling can be triggered by two
ligands (ie, LT and LIGHT).33,60 Because the formation of
pancreatic infiltrates in RIP-CXCL13 transgenic mice was
largely dependent on LT21 and the effects of LIGHT defi-
ciency on lymphoid organ development are minor com-
pared with LT,60 we suggest that LT is likely to be the
dominant LTR ligand for TLT formation. Signaling via LTR
on stromal cells is thought to be the key pathway inducing
the expression of CCL19 and CCL21 in TRCs and of
CXCL13 in FDCs. Because these chemokines, in turn, at-
tract lymphocytes and further induce their LT expres-
sion,55,60 this stromal-hematopoietic cross talk may lead to
a positive feedback loop, allowing the further growth and
organization of infiltrates, analogous to the process of em-
bryonic LN/PP development. Blocking of LTR signaling in
RIP-CXCL13 tg mice likely interrupts this feedback loop
and leads to a decreased size of the TRC network and
conduit system. Although this may contribute to the reduc-
tion in TLT cellularity, the disappearance of well-differenti-
ated HEVs, expressing integrin ligands, is likely to play an
important role as well.33 In contrast to LNs, neutralization of
LTR signaling in adult mice partially disrupts stromal cell
networks in splenic T and B zones, including CCL21 and
CXCL13 expression.33,55 Therefore, stromal cells in TLTs
resemble those in spleen because both depend on a con-
tinuous dialogue with LT hematopoietic cells. In several
other inflammatory models, such as RIP-CCL21 tg, NOD,
experimental autoimmune encephalitis, apolipoprotein
E/, and influenza-infectedmice, blocking LTR leads to a
strong reduction of TLT size and organization.33,49,61 Be-
cause the associated pathological features were reduced
by this treatment, this pathway holds promise as a future
drug target.33,62
The LT12 signal required for splenic white pulp devel-
opment is given by B cells and possibly LTi cells, whereas
LTi cells are sufficient to provide this signal during early LNand PP development.27,28,34,63 Several recent studies have
suggested that CD4 CD3 LTi cells can persist into adult-
hood. Within the adult spleen, LTi-like cells may have orga-
nized T cell B cell segregation,34 repaired damaged stromal
cell networks,35 and improved memory formation.45 Prelim-
inary evidence37,38,64 suggested a role for LTi cells in
CXCL13- or IL-7–induced TLT formation. We detected a
population of CD4 CD3 cells expressing IL-7R and
LT in the spleen and LNs of adult mice and within pan-
creatic infiltrates of adult RIP-CXCL13 tgmice. They share
this phenotype with neonatal LTi cells and were absent from
the spleen and pancreas of ROR-deficient mice. Surpris-
ingly, the absence of LTi cells reduced the size and orga-
nization of the infiltrate to a similar extent as the lack of
LT.21 The absence of B cells led to even smaller infiltrates,
possibly because B cells are the main cell population at-
tracted by CXCL13.21 The other possibility is that both LTi
and B cells provide LT signals to stromal cell precursors,
possibly in a sequential manner. The appearance of LTi
cells in RIP-CXCL13 pancreata before birth was reported,
with B cells colonizing shortly thereafter.37 Distinct lympho-
cyte accumulations become visible only 1 to 3 weeks after
birth (our unpublished data), indicating that they develop
postnatally, along with nasal-associated lymphoid tissue
and PPs; therefore, they may be considered ectopic LNs.
Because both cell types are still present in the infiltrates of
adult mice, both may contribute to LT-dependent TLT
maintenance. The colocalization of LT LTi cells with
LTR TRCs would be consistent with such an interaction
that may lead to chemokine expression, as reported in other
systems.34,35
The CD4 CD3 cells were also detected in ectopic
lymphoid infiltrates of adult apolipoprotein E/65 and villin-
CXCL13 transgenic mice64; they could play a similar role in
these mice. Ectopic LNs and PPs, developing in IL-7–over-
expressing mice, were ROR and LT dependent, implying
LTi cell involvement.38 In contrast, the lack of LTi cells [due
to deficiency of inhibitor of DNA-binding (Id) 2] or LT did
not influence the formation of TLTs in a model in which
CCL21 expression was expressed in the thyroid.25 This
discrepancy may stem from the potential heterogeneity
among LTi cells, with some being ROR and others being
Id2 dependent.4 Alternatively, the onset of tissue infiltration
may differ, with lymphocytes infiltrating early after birth in
RIP-CXCL13 pancreata and possibly later in CCL21-over-
expressing thyroid. Interestingly, RIP-CCL21 tg pancreata
also contain LTi cells shortly after birth (our unpublished
data), suggesting that both CXCL13 and CCL21 can attract
LTi cells. Yet another difference may be the cell type pro-
viding lymphoid tissue–inducing signals (LT or other)
because B, T, or natural killer cells could replace LTi cells in
their inductive function, especially when they are acti-
vated.60 In many autoimmune diseases, sufficient LT is
likely provided by activated lymphocytes.4 In line with this
notion, we have not been able to reproducibly detect LTi
cells in NOD pancreas (data not shown), possibly because
of the relatively low expression of LTi attractants, such as
CXCL13 and CCL21, at the inflammatory site.20 More stud-
ies4 using different murine TLT models are required to clar-
ify whether LTi cells are a frequent feature of the develop-
ment of ectopic lymphoid structures. Similar studies47
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LTi-like cells have also been recently described. Given that
podoplanin TRC can evolve at sites of acute inflammation
in the absence of LT signals, the pathways leading to
TRC formation are likely to be redundant, thereby increas-
ing the robustness of the system.22
In summary, we demonstrate that the similarities between
SLOs and ectopic lymphoid tissues (TLTs) extend further
than previously appreciated. Lymphocytes, FDCs, and
HEVs are characteristic features, as are the TRC network
and the conduit system. The markers used in this study to
identify TRCs should facilitate further examination of these
cells in inflammatory diseases, both in mice and humans. In
particular, podoplanin as a surface marker will allow isola-
tion of these cells ex vivo and investigation of them further,
both phenotypically and functionally. Finally, because TRCs
are the main producers of the chemokines (ie, CCL19 and
CCL21), TRCs might play an important role in the perpetu-
ation of chronic inflammation and could represent an inter-
esting target for therapy.
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